Mayo Clinic

752 articles with Mayo Clinic

• Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

  8/16/2018

  Elysium Health, Inc.™ has entered into an exclusive license agreement with Mayo Clinic and Harvard University.

• 

  August 10 Research Roundup: Type 2 Diabetes, Breast Cancer, Ebola and Koalas

  8/10/2018

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
• 

  Mayo Clinic Finds Genes Associated with Triple-Negative Breast Cancer

  8/7/2018

  Researchers at the Mayo Clinic, led by geneticist Fergus Couch, identified specific genes associated with triple-negative breast cancer. Triple-negative breast cancer is generally difficult to treat and has a lower five-year survival rate than other types of breast cancer.
• 

  A*STAR Institute and Mayo Clinic Identify Key Protein to Convert Skin Cells into Other Types of C...

  7/12/2018

  A*STAR’s Institute of Molecular & Cell Biology (IMCB) in Singapore, along with the Mayo Clinic, identified a key epigenetic protein called H3.3 that helps convert skin cells into other types of cells via cellular reprogramming.

• Blue Cross and Blue Shield of Minnesota and Mayo Clinic Announce New Five-Year Relationship

  6/18/2018

  Agreement through 2023 emphasizes high-value care, strategic collaboration

• Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma

  6/5/2018

  Data Presented at Digestive Disease Week Show Panel of Six Biomarkers is 95 Percent Sensitive for Most Common Type of Liver Cancer

• Automated Breast Density from Volpara Solutions Strongly Predicts Risk of Screen-Detected and Interval Cancers

  5/1/2018

  Research from University of California San Francisco and the Mayo Clinic Supports the Use of Fully Automated Volpara®Density™ Software to Inform Women of their Breast Density

• Mayo Clinic's Dr. Paul Limburg to join Exact Sciences medical leadership

  3/6/2018

  Dr. Limburg is a gastroenterologist and a professor of medicine at Mayo Clinic. He is also a co-leader of the Cancer Prevention and Control program within Mayo Clinic Cancer Center.

• SkylineDx Inks Joint Development Agreement with Mayo Clinic to Develop Diagnostic Tests for Melanoma

  1/31/2018

  For SkylineDx, the collaboration with the renowned Mayo Clinic is an important milestone as it allows the company to develop new diagnostic tests and extend its product offering for a broader group of patients and clinicians.

• Recovery Force and Mayo Clinic Collaborate on Wearable Med-Tech Garments

  1/25/2018

  The Recovery Force platform embeds shape changing fibers into garments and footwear to create lightweight wearable active compressions providing users with improved circulation and the mobility necessary for a quicker recovery.

• WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services

  1/10/2018

  WuXi AppTec and Mayo Clinic announced today a joint venture to co-develop and deliver clinical diagnostic services in China.

• Veritas Genetics Launches Collaboration With Mayo Clinic to Integrate Whole Genome Sequencing Into Clinical Care

  1/8/2018

  Veritas Genetics, The Genome Company, and Mayo Clinic are entering into an agreement to make whole genome sequencing broadly available to healthy individuals.

• Corindus to Participate With Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities

  1/3/2018

  Corindus announced today that it is working with Mayo Clinic in a preclinical study about use of telestenting. Telestenting, or the remote robotic treatment for percutaneous coronary intervention (PCI).

• PathoQuest and Mayo Clinic Enter Into an Agreement to Conduct Study of iDTECT Blood in Patients With Febrile Neutropenia

  12/14/2017

  PathoQuest announced that it will conduct research with Mayo Clinic to study the company’s proprietary iDTECT Blood test.

• Mayo Clinic to Begin Prospective Clinical Study With Medibio Technology for Expanded Market Opportunities

  12/14/2017

  This initial study, undertakes the prospective diagnosis and longitudinal monitoring of both unipolar and bipolar depression, along with the depressive subtypes (melancholic and atypical).

• sphingotec Announces Collaboration With Mayo Clinic for Evaluation and Use of Biomarkers to Improve Diagnosis of Certain Diseases, Including Kidney Disease, Breast Cancer, Sepsis, and Cardiovascular Disease

  12/1/2017

  Through this agreement, Mayo Clinic will evaluate the biomarkers penKid and three others for research and potential routine clinical use.

• Evelo Biosciences and Mayo Clinic Collaborate to Advance Monoclonal Microbials for the Treatment of Inflammatory and Neuroinflammatory Diseases

  11/16/2017

  In the published studies, the monoclonal microbial, an anaerobic commensal microbe isolated from a human biopsy sample, led to a decrease in activity of Th17 inflammatory cells and an increase in the activity and frequency of regulatory T-cells.

• MediPines Acquires Oxistimulator Technology From Mayo Clinic

  11/2/2017

  MediPines announced today that it has acquired medical technology designed to reduce respiratory complications in post-surgical patients by preventing oxygen desaturations.

• Boston Scientific, Mayo Clinic File Joint Patent App for Self-Centering TAVR Cath

  10/13/2017

• Mayo Clinic’s Collaboration with Startup NeuroOne Includes an 11 Percent Stake

  8/3/2017